SLDB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.63%

Insider Buying (Last 12 Months): $18,369.40

Insider Selling (Last 12 Months): $161,072.73

Solid Biosciences Insider Trading History Chart

Solid Biosciences Share Price & Price History

^$2.55

▲ +0.03 (1.19%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Solid Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2025	Clare Kahn	Director	Buy	1,860	$5.34	$9,932.40	2,960
1/28/2025	Ilan Ganot	Director	Sell	144	$3.11	$447.84	11,689
1/10/2025	Kevin Tan	CFO	Sell	4,073	$3.89	$15,843.97	24,789
1/6/2025	Ilan Ganot	Director	Sell	1,056	$4.31	$4,551.36	11,445
12/3/2024	Alexander Cumbo	CEO	Sell	11,114	$5.60	$62,238.40	38,484
12/3/2024	David T Howton	COO	Sell	5,072	$5.60	$28,403.20	15,663
12/3/2024	Jessie Hanrahan	Insider	Sell	4,610	$5.60	$25,816.00	14,235
10/21/2024	Gabriel Brooks	Insider	Sell	2,923	$6.50	$18,999.50	10,979
6/7/2024	Clare Kahn	Director	Buy	1,100	$7.67	$8,437.00	1,100
5/2/2024	Ilan Ganot	Director	Sell	462	$10.33	$4,772.46	9,507
1/29/2024	Ilan Ganot	Director	Sell	139	$7.99	$1,110.61	8,416
1/11/2024	Perceptive Advisors Llc	Director	Buy	3,410,713	$5.53	$18,861,242.89	6,833,539
1/9/2024	Kevin Tan	CFO	Sell	3,935	$8.20	$32,267.00	9,308
1/3/2024	Ilan Ganot	Director	Sell	1,142	$5.30	$6,052.60	8,167
12/4/2023	Alexander Cumbo	CEO	Sell	11,757	$2.77	$32,566.89	17,439
12/4/2023	David T Howton	COO	Sell	5,367	$2.78	$14,920.26	7,684
12/4/2023	Jessie Hanrahan	Insider	Sell	4,879	$2.78	$13,563.62	6,983
12/4/2023	Paul Herzich	CTO	Sell	2,968	$2.77	$8,221.36	4,270
5/2/2023	Ilan Ganot	Director	Sell	487	$4.85	$2,361.95	4,153
1/27/2023	Carl Ashley Morris	Insider	Sell	441	$7.49	$3,303.09	19,760
1/27/2023	Ilan Ganot	Director	Sell	1,382	$7.49	$10,351.18	84,591

See Full Table

SEC Filings (Institutional Ownership Changes) for Solid Biosciences (NASDAQ:SLDB)

81.46% of Solid Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Solid Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/8/2025	Rhumbline Advisers	39,422	$0.15M	0.0%	-9.7%	0.051%
3/24/2025	Wellington Management Group LLP	124,551	$0.50M	0.0%	+4.0%	0.161%
2/17/2025	Vestal Point Capital LP	2,850,000	$11.40M	0.7%	+1.8%	7.132%
2/17/2025	Two Sigma Advisers LP	24,373	$97K	0.0%	-59.8%	0.061%
2/17/2025	Two Sigma Investments LP	136,145	$0.55M	0.0%	-32.9%	0.341%
2/17/2025	Sherbrooke Park Advisers LLC	15,768	$63K	0.0%	-54.0%	0.039%
2/17/2025	Redmile Group LLC	615,246	$2.46M	0.2%	N/A	1.540%
2/17/2025	Nuveen Asset Management LLC	197,929	$0.79M	0.0%	-2.3%	0.495%
2/17/2025	Millennium Management LLC	719,776	$2.88M	0.0%	-35.6%	1.801%
2/17/2025	D. E. Shaw & Co. Inc.	51,972	$0.21M	0.0%	N/A	0.130%
2/17/2025	Corton Capital Inc.	10,152	$41K	0.0%	N/A	0.025%
2/17/2025	Cubist Systematic Strategies LLC	65,613	$0.26M	0.0%	+479.4%	0.164%
2/17/2025	Bridgeway Capital Management LLC	102,631	$0.41M	0.0%	+101.0%	0.257%
2/17/2025	Bank of America Corp DE	83,471	$0.33M	0.0%	+87.9%	0.209%
2/17/2025	BNP Paribas Financial Markets	44,117	$0.18M	0.0%	N/A	0.110%
2/17/2025	Algert Global LLC	22,089	$88K	0.0%	+45.7%	0.055%
2/14/2025	Monashee Investment Management LLC	480,000	$1.92M	0.3%	-1.0%	1.201%
2/14/2025	Northern Trust Corp	169,100	$0.68M	0.0%	-4.0%	0.423%
2/14/2025	Adage Capital Partners GP L.L.C.	1,748,084	$6.99M	0.0%	-0.3%	4.375%
2/14/2025	Dimensional Fund Advisors LP	264,069	$1.06M	0.0%	+270.1%	0.661%
2/13/2025	Marshall Wace LLP	181,501	$0.73M	0.0%	-3.1%	0.454%
2/13/2025	Walleye Capital LLC	158,831	$0.64M	0.0%	-59.5%	0.397%
2/13/2025	Barclays PLC	54,560	$0.22M	0.0%	-13.2%	0.137%
2/13/2025	Renaissance Technologies LLC	82,493	$0.33M	0.0%	+12.7%	0.206%
2/13/2025	Invesco Ltd.	12,237	$49K	0.0%	N/A	0.031%
2/13/2025	ADAR1 Capital Management LLC	148,903	$0.60M	0.1%	-87.0%	0.373%
2/13/2025	Wells Fargo & Company MN	13,138	$53K	0.0%	+29.4%	0.033%
2/12/2025	Trexquant Investment LP	194,281	$0.78M	0.0%	+256.9%	0.486%
2/12/2025	Geode Capital Management LLC	509,802	$2.04M	0.0%	+1.0%	1.276%
2/12/2025	Wellington Management Group LLP	124,551	$0.50M	0.0%	+4.0%	0.312%
2/12/2025	JPMorgan Chase & Co.	955,932	$3.82M	0.0%	+9,393.8%	2.392%
2/11/2025	Prudential Financial Inc.	109,105	$0.44M	0.0%	+71.3%	0.273%
2/11/2025	Sei Investments Co.	13,078	$52K	0.0%	N/A	0.033%
2/11/2025	American Century Companies Inc.	46,857	$0.19M	0.0%	+12.3%	0.117%
1/30/2025	Quantum Private Wealth LLC	57,333	$0.23M	0.1%	+81.8%	0.143%
1/30/2025	Rhumbline Advisers	43,677	$0.18M	0.0%	+10.5%	0.109%
1/24/2025	China Universal Asset Management Co. Ltd.	8,472	$34K	0.0%	N/A	0.021%
11/19/2024	Barclays PLC	62,856	$0.44M	0.0%	+412.1%	0.157%
11/16/2024	Geode Capital Management LLC	504,870	$3.52M	0.0%	-1.7%	1.263%
11/15/2024	Barclays PLC	62,856	$0.44M	0.0%	+412.1%	0.157%
11/15/2024	XTX Topco Ltd	17,370	$0.12M	0.0%	N/A	0.043%
11/15/2024	Jane Street Group LLC	20,810	$0.15M	0.0%	-20.3%	0.052%
11/15/2024	Wellington Management Group LLP	119,804	$0.84M	0.0%	+183.6%	0.300%
11/15/2024	State Street Corp	441,540	$3.08M	0.0%	+9.2%	1.105%
11/15/2024	Point72 Asset Management L.P.	443,010	$3.09M	0.0%	+292.8%	1.109%
11/14/2024	Vestal Point Capital LP	2,800,000	$19.52M	1.5%	+5.1%	7.008%
11/14/2024	Walleye Capital LLC	392,101	$2.73M	0.0%	-4.8%	0.981%
11/14/2024	MetLife Investment Management LLC	13,699	$95K	0.0%	+129.1%	0.034%
11/13/2024	FMR LLC	43,761	$0.31M	0.0%	N/A	0.110%
11/13/2024	The Manufacturers Life Insurance Company	10,116	$71K	0.0%	N/A	0.025%
11/12/2024	Valence8 US LP	15,728	$0.11M	0.0%	N/A	0.039%
11/4/2024	Los Angeles Capital Management LLC	42,059	$0.29M	0.0%	N/A	0.109%
11/1/2024	Quantum Private Wealth LLC	31,533	$0.22M	0.1%	N/A	0.082%
9/16/2024	Point72 DIFC Ltd	10,206	$58K	0.0%	N/A	0.026%
9/16/2024	Cubist Systematic Strategies LLC	72,645	$0.41M	0.0%	N/A	0.188%
8/19/2024	Point72 Asset Management L.P.	112,776	$0.64M	0.0%	N/A	0.292%
8/16/2024	Algert Global LLC	14,479	$82K	0.0%	N/A	0.038%
8/15/2024	Susquehanna Fundamental Investments LLC	16,200	$92K	0.0%	N/A	0.042%
8/15/2024	Millennium Management LLC	1,728,065	$9.80M	0.0%	+135.7%	4.503%
8/15/2024	Deerfield Management Company L.P. Series C	1,743,398	$9.89M	0.2%	-22.9%	4.542%
8/14/2024	Cubist Systematic Strategies LLC	72,645	$0.41M	0.0%	N/A	0.189%
8/14/2024	Point72 DIFC Ltd	10,206	$58K	0.0%	N/A	0.027%
8/14/2024	Marshall Wace LLP	274,005	$1.55M	0.0%	N/A	0.714%
8/9/2024	Renaissance Technologies LLC	277,564	$1.57M	0.0%	+303.6%	0.723%
8/9/2024	Dimensional Fund Advisors LP	70,827	$0.40M	0.0%	+8.1%	0.185%
8/8/2024	American Century Companies Inc.	34,557	$0.20M	0.0%	+39.9%	0.090%
8/8/2024	Ground Swell Capital LLC	13,469	$76K	0.1%	N/A	0.035%
8/6/2024	Acadian Asset Management LLC	67,073	$0.38M	0.0%	N/A	0.175%
8/1/2024	Rhumbline Advisers	33,773	$0.19M	0.0%	N/A	0.088%
7/26/2024	Bank of New York Mellon Corp	69,107	$0.39M	0.0%	N/A	0.180%
5/17/2024	RA Capital Management L.P.	4,330,446	$57.68M	0.7%	+26.4%	11.438%
5/17/2024	Artal Group S.A.	2,500,000	$33.30M	0.8%	+175.0%	6.603%
5/16/2024	Janus Henderson Group PLC	1,808,440	$23.94M	0.0%	N/A	4.777%
5/16/2024	Bain Capital Life Sciences Investors LLC	4,034,582	$53.74M	4.3%	+28.9%	10.657%
5/10/2024	Vanguard Group Inc.	1,244,575	$16.58M	0.0%	+283.9%	3.287%
2/14/2024	Vestal Point Capital LP	34,085	$0.21M	0.0%	N/A	0.169%
8/15/2023	Caas Capital Management LP	101,681	$0.53M	0.0%	-58.4%	0.519%
8/14/2023	Great Point Partners LLC	584,458	$3.06M	0.6%	+177.8%	2.982%
5/16/2023	Great Point Partners LLC	210,405	$1M	0.2%	N/A	1.073%
5/12/2023	Finepoint Capital LP	488,857	$2.32M	0.9%	+123.7%	2.496%
5/9/2023	Tower Research Capital LLC TRC	23,950	$0.11M	0.0%	+102.1%	0.122%
2/14/2023	RA Capital Management L.P.	3,426,286	$18.43M	0.4%	-72.3%	45.502%
2/13/2023	Finepoint Capital LP	218,562	$1.18M	0.4%	N/A	2.903%
2/13/2023	Artal Group S.A.	909,219	$4.89M	0.3%	-69.7%	12.075%
2/10/2023	K2 Principal Fund L.P.	342,271	$1.84M	0.3%	-93.8%	4.545%
11/14/2022	Ergoteles LLC	204,263	$95K	0.0%	-20.2%	2.710%
8/15/2022	Laurion Capital Management LP	1,156,600	$0.71M	0.0%	N/A	1.025%
7/14/2022	Highland Private Wealth Management	89,340	$55K	0.0%	N/A	0.079%
5/16/2022	Suvretta Capital Management LLC	7,224,860	$8.67M	0.3%	+14.9%	6.404%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	21,001	$25K	0.0%	-85.0%	0.019%
5/5/2022	Russell Investments Group Ltd.	28,275	$33K	0.0%	N/A	0.025%
2/14/2022	Boxer Capital LLC	3,177,702	$5.56M	0.2%	-14.9%	2.881%
2/14/2022	Suvretta Capital Management LLC	6,287,193	$11M	0.2%	+5.2%	5.700%
2/14/2022	GSA Capital Partners LLP	113,104	$0.20M	0.0%	+12.4%	0.103%
2/10/2022	Bailard Inc.	53,400	$93K	0.0%	N/A	0.048%
2/10/2022	Acadian Asset Management LLC	123,406	$0.21M	0.0%	N/A	0.112%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	140,285	$0.25M	0.0%	+59.8%	0.127%
2/8/2022	ProShare Advisors LLC	28,560	$49K	0.0%	N/A	0.026%
2/7/2022	SG Americas Securities LLC	16,870	$30K	0.0%	-52.7%	0.015%
2/1/2022	Assenagon Asset Management S.A.	25,893	$45K	0.0%	N/A	0.023%

Data available starting January 2016

See Full Table

Solid Biosciences Inc., a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, a gene transfer candidate for the treatment of Duchenne muscular dystrophy; and SGT-501 to treat Catecholaminergic polymorphic ventricular tachycardia. It is also developing AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy; SGT-601 to treat a rare cardiac disease characterized by mutations in the gene that codes for cardiac troponin T protein, which helps coordinate contraction of the heart muscle; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, a cardiac splicing factor that regulates alternative splicing, and codes for RNA binding motif protein 20; and AVB-202-TT to treat Friedreich's ataxia, as well as other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne; and a license agreement with the University of Washington, University of Missouri, and University of Florida. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.

Today's Range

Now: $2.55

$2.45

$2.61

50 Day Range

MA: $4.34

$2.52

$6.47

52 Week Range

Now: $2.55

$2.45

$10.99

Volume

1,541,997 shs

Average Volume

900,235 shs

Market Capitalization

$197.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.07

Who are the company insiders with the largest holdings of Solid Biosciences?: Solid Biosciences' top insider shareholders include:
Perceptive Advisors Llc (Director)
Alexander Cumbo (CEO)
Kevin Tan (CFO)
David T Howton (COO)
Jessie Hanrahan (Insider)
Ilan Ganot (Director)
Gabriel Brooks (Insider)
Paul Herzich (CTO)
Clare Kahn (Director)
Learn More about top insider investors at Solid Biosciences.
Who are the major institutional investors of Solid Biosciences?: Solid Biosciences' top institutional shareholders include:
Rhumbline Advisers — 0.05%
Learn More about top institutional investors of Solid Biosciences stock.
Which major investors are selling Solid Biosciences stock?: In the previous quarter, SLDB stock was sold by these institutional investors:
Rhumbline Advisers
In the last year, company insiders that have sold Solid Biosciences company stock include:
Perceptive Advisors Llc (Director)
Alexander Cumbo (CEO)
Kevin Tan (CFO)
David T Howton (COO)
Jessie Hanrahan (Insider)
Ilan Ganot (Director)
Learn More investors selling Solid Biosciences stock.